Type of Cancer
Multiple Myeloma
Phase
Division (Location)
Study ID
NCT#
Brief Description
BMT CTN PROTOCOL 1302, Multicenter Phase II, Double Blind, Placebo Controlled Trial of Maintenance Ixazomib after Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Multiple Myeloma
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.